论文部分内容阅读
目的:评价氧氟沙星对肝硬化上消化道出血患者医院感染的预防作用。方法:选取2014年1月—2015年12月间收治的肝硬化上消化道出血患者80例,按随机序号法将其分为对照组和观察组,每组40例;对照组患者仅给予常规预防处理不使用抗菌药物,观察组患者在常规预防处理的基础上加用氧氟沙星治疗,评价两组患者治疗后的感染发生率、并发症和上消化道出血的复发率。结果:观察组患者用药后的感染发生率为7.50%低于对照组为25.00%(P<0.05);非感染患者上消化道出血的复发率为4.48%(3/67)低于感染患者为38.46%(5/13)(P<0.05)。结论:采用氧氟沙星对肝硬化患者上消化道出血医院感染的预防作用较好,明显降低了其复发率。
Objective: To evaluate the preventive effect of ofloxacin on nosocomial infections in cirrhotic patients with upper gastrointestinal bleeding. Methods: Eighty patients with cirrhosis and upper gastrointestinal hemorrhage admitted from January 2014 to December 2015 were selected and randomly divided into control group and observation group, 40 cases in each group. Patients in the control group were given conventional Preventive treatment did not use antimicrobial drugs. Patients in the observation group were treated with ofloxacin on the basis of routine preventive treatment to evaluate the incidence of infection, complications and the recurrence rate of upper gastrointestinal bleeding after treatment in both groups. Results: The incidence of infection in observation group was 7.50% lower than that in control group (P <0.05). The recurrence rate of upper gastrointestinal bleeding in non-infected patients was 4.48% (3/67) lower than that in infected patients 38.46% (5/13) (P <0.05). CONCLUSION: Ofloxacin has a good preventive effect on nosocomial infection of upper gastrointestinal bleeding in patients with cirrhosis and significantly reduces the recurrence rate.